Julius Strauss

10PUBLICATIONS
32CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 07, 2023
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.

Thomas A Odeny, Kathryn Lurain, Julius Strauss

|Jun 13, 2023
Avelumab in Patients With Metastatic Colorectal Cancer.

Jason M Redman, Geraldine O'Sullivan Coyne, Clay T Reed

|May 03, 2023
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.

Ravi A Madan, Marijo Bilusic, Mark N Stein

|Jan 14, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.

Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss

|Jul 06, 2022
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors.

John S Davies, Farrah Karimipour, Ling Zhang

Pageof 2